Health Condition 1: K137- Other and unspecified lesions of oral mucosa
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients with clinically diagnosed atrophic/erosive OLP(based on modified WHO clinical criteria, 2003) 2 Individuals willing to be a part of the study, who sign the informed consent form, and who find it convenient to appear for follow-ups as required by the study. 3 Patients who had not used systemic or topical glucocorticosteroids for at least the past 2 weeks 4 Patients who agree not to use any other medication such as analgesics and Anesthetics in either topical form or systemic form during the study.
Exclusion criteria
Exclusion criteria: 1 Patients with lichenoid lesions thought to arise as a hypersensitivity reaction to drugs and dental materials 2 Patients on long-term glucocorticosteroid therapy 3 Pregnant and lactating female patients 4 Patients allergic to bee products
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of topical propolis in comparison with topical triamcinolone acetonide in symptomatic oral lichen planus in following parameters 1. Pain 2. Erythema and ulceration 3. Side effects Timepoint: The active treatment duration for each group will be for a period of 15 days. The patients will be recalled and scheduled for an appointment on 7th and 15th day and the clinical evaluation will be done and recorded. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Sinhgad dental college and hospital, Pune